TYRX's first commercially available product is the AIGISRx Antibacterial Envelope for cardiac implantable electronic devices (CIEDs).

The AIGISRx is intended to securely hold a pacemaker or defibrillator in place to create a stable environment.

More information can be found at AIGISRx Antibacterial Envelope.

News & Events

Steep Decline in CIED Infections Reported with use of AIGISRx Antibacterial Envelope 

· ACC 2012 Poster Presentation – "Infections in High-Risk Patients with an Implanted Antibacterial Envelope"

· Presented by Chris Ellis, MD, Vanderbilt Heart & Vascular Institute

· Results show 0% CIED infections in patients who received AIGISRx implants, compared to 3% in control group (p=0.006).

See Attached Link:

ACC 2012 Scientific Sessions Poster Presentation  (Presentation #1244-501)